Clinuvel Pharmaceuticals Limited: updates and filings

CUVLNASDAQTechnology · American Depositary Receipts

Price

$4.66

November 20, 2026Market cap $235M

What Ploutos Investor adds for Clinuvel Pharmaceuticals

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 3 fiscal years, from FY2024
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Oct 30, 2026 latest annual
  • Oct 30, 2026Annual report (foreign company)for the period to Jun 30, 2026
    Form20-F
  • Oct 30, 2026Current report (foreign company)
    Form6-K
  • Oct 15, 2026Current report (foreign company)
    Form6-K
  • Oct 7, 2026Current report (foreign company)
    Form6-K
  • Oct 2, 2026Current report (foreign company)
    Form6-K
  • Oct 1, 2026Current report (foreign company)
    Form6-K
  • Sep 9, 2026Current report (foreign company)
    Form6-K
  • Aug 27, 2026Current report (foreign company)
    Form6-K
  • Aug 20, 2026Current report (foreign company)
    Form6-K
  • Aug 12, 2026Current report (foreign company)
    Form6-K
  • Jul 30, 2026Current report (foreign company)
    Form6-K
  • Jul 28, 2026Current report (foreign company)
    Form6-K
  • Jul 27, 2026Current report (foreign company)
    Form6-K
  • Jul 23, 2026Current report (foreign company)
    Form6-K
  • Jul 22, 2026Current report (foreign company)
    Form6-K
  • Jul 22, 2026Current report (foreign company)
    Form6-K
  • Jul 17, 2026Filing
    FormSEC STAFF ACTION
  • Jul 17, 2026Exchange certification of a listing
    FormCERT
  • Jul 15, 2026Correspondence with the SEC
    FormCORRESP
  • Jul 9, 2026Correspondence with the SEC
    FormCORRESP
  • Jul 6, 2026Correspondence with the SEC
    FormCORRESP
  • Jun 15, 2026Correspondence with the SEC
    FormCORRESP
  • Jun 15, 2026Filing
    Form20FR12B
  • Apr 23, 2026Letter from the SEC
    FormUPLOAD
  • Apr 17, 2026Filing
    FormDRSLTR

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since May 7, 2004.

The full analysis

What do Clinuvel Pharmaceuticals's filings show?

The filings are where every one of Clinuvel Pharmaceuticals's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.